10,000 PATIENTS ENROLLED IN ONCOLOGY STUDIES
In 2021, Cromos Pharma achieved an important milestone as it reached 10,000 patients enrolled in its oncological studies. Cromos Pharma also managed its first trial investigating a vaccine for COVID-19.
2021